de novo design in the synthetically accessible compounds universe

webinar

Tue, 23 Feb 2016, 16:00 CET (Berlin)

Dr. Christian Lemmen, BioSolveIT GmbH, St. Augustin, Germany

de novo design in the synthetically accessible compounds universe

No matter how big your in-house library and no matter how many compounds you acquire as supplement, it merely scratches the surface of what chemists are capable of synthesizing. Recent publications indicate that the majority of chemical space is defined on the basis of only 50-70 robust chemical reactions. We have used these to compile a Chemical Space comprising billions of virtual compounds with high likelihood of straight forward synthetic access. We make this literature-derived collection publicly available and also provide a unique similarity search method capable to explore such wealth of data. Imagine de novo design of (a) hit expansion libraries, (b) follow-up series and (c) fragment evolution designs from within an all accessible compound space. We will demonstrate how this can become reality.

Current news

Tool of the Month - infiniSee 7.1 'Arke'
May 27, 2026 09:44 CEST
Navigate Chemical Space with infiniSee 7.1 ‘Arke’ The ultimate platform for exploring ultra-large Chemical Spaces is taking a huge leap forward. Combining our Tool of the Month series with an exciting software release, we are happy to present infiniSee 7.1 ‘Arke’. Allowing you to search deeper and evaluate compounds more...
Read on
category
Software
infiniSee 7.1 'Arke' Is Now Available
May 26, 2026 16:49 CEST
We are delighted to introduce infiniSee 7.1 ‘Arke’, another helpful step forward in making the exploration of vast Chemical Spaces faster, clearer, and more intuitive. With this update, we focused on two central goals: helping users move through ultra-large Chemical Spaces more efficiently and making compound assessment more visual and...
Read on
VAST™ Space by XtalPi - Access now with our tools
May 21, 2026 10:42 CEST
The VAST™ Space brings an actionable, navigable universe of 4.66 billion accessible, drug-like products directly into your workflow. Created by XtalPi, this collection was built from 40+ validated reaction protocols and 58,000 in-stock building blocks. By pairing automated synthesis with proprietary feasibility models, it delivers a highly reliable and innovative...
Read on